Standard Biotools Inc (LAB) — Working Capital to Net Assets Ratio
Standard Biotools Inc (LAB) has a Working Capital to Net Assets ratio of 85.4% as of March 2026. Working capital of $479.25 Million (current assets of $521.45 Million minus current liabilities of $42.20 Million) is measured against net assets of $561.12 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See LAB equity to assets ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Standard Biotools Inc Working Capital to Net Assets (2006–2025)
This chart shows how Standard Biotools Inc's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the ratio stands at 85.4%, reflecting working capital of $479.25 Million against net assets of $561.12 Million USD. Check Standard Biotools Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Standard Biotools Inc (2006–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Standard Biotools Inc from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see LAB market cap.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 81.5% | $345.96 Million | $424.29 Million | $454.26 Million | $108.31 Million | ▲ +15.8 pp |
| 2024 | 65.7% | $309.99 Million | $471.72 Million | $375.88 Million | $65.89 Million | ▲ +98.7 pp |
| 2023 | -33.0% | $48.89 Million | $-148.05 Million | $158.22 Million | $109.33 Million | ▲ +170.0 pp |
| 2022 | -203.0% | $165.37 Million | $-81.47 Million | $208.81 Million | $43.44 Million | ▼ -226.8 pp |
| 2021 | 23.8% | $22.50 Million | $94.60 Million | $72.07 Million | $49.57 Million | ▼ -21.8 pp |
| 2020 | 45.6% | $63.41 Million | $139.05 Million | $117.66 Million | $54.25 Million | ▲ +4.4 pp |
| 2019 | 41.2% | $63.27 Million | $153.61 Million | $96.10 Million | $32.82 Million | ▼ -82.9 pp |
| 2018 | 124.1% | $89.52 Million | $72.12 Million | $127.11 Million | $37.58 Million | ▼ -74.1 pp |
| 2017 | 198.2% | $61.33 Million | $30.93 Million | $94.80 Million | $33.47 Million | ▲ +72.1 pp |
| 2016 | 126.2% | $67.17 Million | $53.23 Million | $96.67 Million | $29.50 Million | ▲ +27.0 pp |
| 2015 | 99.2% | $114.01 Million | $114.90 Million | $144.09 Million | $30.08 Million | ▲ +15.1 pp |
| 2014 | 84.1% | $126.51 Million | $150.42 Million | $155.90 Million | $29.39 Million | ▼ -5.8 pp |
| 2013 | 89.9% | $87.34 Million | $97.12 Million | $104.58 Million | $17.25 Million | ▲ +0.9 pp |
| 2012 | 89.0% | $89.61 Million | $100.66 Million | $101.21 Million | $11.60 Million | ▲ +1.4 pp |
| 2011 | 87.6% | $49.86 Million | $56.90 Million | $70.03 Million | $20.17 Million | ▲ +88.9 pp |
| 2010 | -1.3% | $2.37 Million | $-189.17 Million | $20.88 Million | $18.51 Million | ▲ +11.0 pp |
| 2009 | -12.3% | $21.35 Million | $-173.62 Million | $28.48 Million | $7.13 Million | ▲ +0.8 pp |
| 2008 | -13.1% | $20.70 Million | $-158.34 Million | $29.23 Million | $8.52 Million | ▲ +16.7 pp |
| 2007 | -29.7% | $38.75 Million | $-130.33 Million | $50.33 Million | $11.57 Million | ▼ -7.2 pp |
| 2006 | -22.5% | $23.94 Million | $-106.17 Million | $31.09 Million | $7.15 Million | — |